Back to Search Start Over

Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort

Authors :
Linda A.J. Hendricks
Nicoline Hoogerbrugge
Hanka Venselaar
Stefan Aretz
Isabel Spier
Eric Legius
Hilde Brems
Robin de Putter
Kathleen B.M. Claes
D. Gareth Evans
Emma R. Woodward
Maurizio Genuardi
Fulvia Brugnoletti
Yvette van Ierland
Kim Dijke
Emma Tham
Bianca Tesi
Janneke H.M. Schuurs-Hoeijmakers
Maud Branchaud
Hector Salvador
Arne Jahn
Simon Schnaiter
Violetta Christophidou Anastasiadou
Joan Brunet
Carla Oliveira
Laura Roht
Ana Blatnik
Arvids Irmejs
Arjen R. Mensenkamp
Janet R. Vos
Floor Duijkers
Jacques C. Giltay
Liselotte P. van Hest
Tjitske Kleefstra
Edward M. Leter
Maartje Nielsen
Sebastiaan W.R. Nijmeijer
Maran J.W. Olderode-Berends
Human genetics
Cancer Center Amsterdam
CCA - Cancer biology and immunology
Clinical Genetics
MUMC+: DA KG Polikliniek (9)
RS: FHML non-thematic output
Source :
European Journal of Medical Genetics, 65(12):104632. Elsevier Masson SAS, European journal of medical genetics, 65(12):104632. ELSEVIER SCIENCE BV, European Journal of Medical Genetics, 65(12):104632. Elsevier Masson, EUROPEAN JOURNAL OF MEDICAL GENETICS, European Journal of Medical Genetics, 65, 12, PTEN Study Group 2022, ' Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort ', European Journal of Medical Genetics, vol. 65, no. 12, 104632 . https://doi.org/10.1016/j.ejmg.2022.104632, European Journal of Medical Genetics, 65(12). Elsevier, European Journal of Medical Genetics, 65
Publication Year :
2022

Abstract

BACKGROUND: Pathogenic PTEN germline variants cause PTEN Hamartoma Tumor Syndrome (PHTS), a rare disease with a variable genotype and phenotype. Knowledge about these spectra and genotype-phenotype associations could help diagnostics and potentially lead to personalized care. Therefore, we assessed the PHTS genotype and phenotype spectrum in a large cohort study. METHODS: Information was collected of 510 index patients with pathogenic or likely pathogenic (LP/P) PTEN variants (n = 467) or variants of uncertain significance. Genotype-phenotype associations were assessed using logistic regression analyses adjusted for sex and age. RESULTS: At time of genetic testing, the majority of children (n = 229) had macrocephaly (81%) or developmental delay (DD, 61%), and about half of the adults (n = 238) had cancer (51%), macrocephaly (61%), or cutaneous pathology (49%). Across PTEN, 268 LP/P variants were identified, with exon 5 as hotspot. Missense variants (n = 161) were mainly located in the phosphatase domain (PD, 90%) and truncating variants (n = 306) across all domains. A trend towards 2 times more often truncating variants was observed in adults (OR = 2.3, 95%CI = 1.5-3.4) and patients with cutaneous pathology (OR = 1.6, 95%CI = 1.1-2.5) or benign thyroid pathology (OR = 2.0, 95%CI = 1.1-3.5), with trends up to 2-4 times more variants in PD. Whereas patients with DD (OR = 0.5, 95%CI = 0.3-0.9) or macrocephaly (OR = 0.6, 95%CI = 0.4-0.9) had about 2 times less often truncating variants compared to missense variants. In DD patients these missense variants were often located in domain C2. CONCLUSION: The PHTS phenotypic diversity may partly be explained by the PTEN variant coding effect and the combination of coding effect and domain. PHTS patients with early-onset disease often had missense variants, and those with later-onset disease often truncating variants. ispartof: EUROPEAN JOURNAL OF MEDICAL GENETICS vol:65 issue:12 ispartof: location:Netherlands status: published

Details

ISSN :
17697212 and 18780849
Database :
OpenAIRE
Journal :
European Journal of Medical Genetics, 65(12):104632. Elsevier Masson SAS, European journal of medical genetics, 65(12):104632. ELSEVIER SCIENCE BV, European Journal of Medical Genetics, 65(12):104632. Elsevier Masson, EUROPEAN JOURNAL OF MEDICAL GENETICS, European Journal of Medical Genetics, 65, 12, PTEN Study Group 2022, ' Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort ', European Journal of Medical Genetics, vol. 65, no. 12, 104632 . https://doi.org/10.1016/j.ejmg.2022.104632, European Journal of Medical Genetics, 65(12). Elsevier, European Journal of Medical Genetics, 65
Accession number :
edsair.doi.dedup.....1b579f2ee726b8aee2834cd899346bae
Full Text :
https://doi.org/10.1016/j.ejmg.2022.104632